Episodes

Allison J. Applebaum, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY Recorded on June 26, 2020 Caregivers of patients diagnosed with cancer often don’t allow themselves to connect to the negative emotions that arise. Discussion with Dr. Allison Applebaum focuses on the importance of coaching caregivers to ask for help, problem solve, formulate questions to ask the oncologist, have potentially challenging conversations with their loved one, and to receive professional and peer supp...

Carma Bylund, PhD, FACH, and Carla Fisher, PhD Recorded on August 13, 2020 Young adults (YAs) are navigating physical, cognitive, and psychological changes, and transitioning into a more independent time of their life including social life and making more decisions on their own. They often grapple with unique issues when faced with a cancer diagnosis. Carma Bylund, PhD, FACH and Carla Fisher, PhD discuss how best to communicate with these young adults. They describe techniques and tips for car...

Nicole Gutman, MS, and Mary Kay Irwin, EdD Recorded on May 19, 2020 Children, adolescents, and young adults (AYAs) face unique challenges when returning to school during or after cancer treatment. In this episode, Nicole Gutman, MS, a School Intervention Consultant, and Mary Kay Irwin, EdD, Director of School Health, at Nationwide Children’s Hospital, describe the psychosocial, educational, and cognitive effects cancer has on a child/AYA, their parents, siblings, and classmates. They discuss a...

James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL Recorded on May 28, 2020 Listen in as Dr. James Foran from Mayo Clinic defines MDS, discusses the diagnostic workup and factors used to develop a treatment plan, including the importance of the morphology of the bone marrow and the blast count, cytogenetics and next generation sequencing and patient management strategies for low and high-risk MDS. The conversation continues with potentially exciting treatment options being ...

Jennifer Levine, MD, and Maria Luisa Sulis, MD, MS Recorded on June 5, 2020 Since its rise, the conversation surrounding the impact of COVID-19 has been primarily around adults patients. But how does this virus effect pediatric patients, specifically those with a cancer diagnosis? Drs. Jennifer Levine from Weill Cornell Medicine, and Maria Luisa Sulis from Memorial Sloan Kettering Cancer Center, discuss the severity of illness across pediatric patients with hematologic malignancies, multisyste...

Alison Loren, MD, MSCE, Raymond and Ruth Perelman School of Medicine, Philadelphia, PA Recorded on April 21, 2020 Living with a chronic disease brings with it distinctive and often challenging psychosocial, emotional, and financial challenges. Tune in to this episode as Dr. Alison Loren from The University of Pennsylvania, describes many of the survivorship challenges her patients living with chronic myeloid leukemia face, as well as an understanding of a CML diagnosis and need for cutting edg...

Raajit K. Rampal, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY Recorded on March 24, 2020 Myeloproliferative neoplasms are an interesting and complex group of blood cancers. Join Dr. Ken Miller as he speaks with Dr. Raajit K. Rampal of Memorial Sloan-Kettering Cancer Center, on how these diseases are categorized and treated. Dr. Rampal shares his insights into disease overlap, disease progression, symptom management, emerging treatment options, and much more. Raajit K. Rampal...

Tobias M. Hohl, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY Recorded on April 15, 2020 As COVID-19 continues to dramatically change the healthcare landscape across the country and the world, what important information do healthcare professionals need to know? In this special episode, Tobias M. Hohl, MD, PhD, Chief, Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center in New York, discusses the biology of the disease, what makes it so contagious, the danger of...

Kerry Cook, PA-C, New York Presbyterian/Columbia University Irving Medical Center, New York, NY Recorded on April 8, 2020 The uncertainty surrounding the COVID-19 pandemic is particularly worrisome to vulnerable populations, particularly cancer patients. How do oncology healthcare professionals care for their patients, each other, and themselves during this time? Join Dr. Miller as he speaks with Kerry Cook, a Senior Physician Assistant of Malignant Hematology at New York Presbyterian/Columbia...

Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center, Seattle, WA Recorded on February 4, 2020 In this special episode, Dr. Miller sits down with Dr. Frederick Appelbaum, Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center, Professor, Division of Medical Oncology, at the University Of Washington School Of Medicine in Seattle, WA to discuss the history, current treatment and future of hematopoietic stem cell transplantation (HSCT) to treat blood ca...

Edith P. Mitchell, MD, MACP, FCPP, Sydney Kimmel Cancer Center at Jefferson, Philadelphia, PA Recorded on January 15, 2020 Thirty-two thousand Americans are diagnosed with myeloma each year and 13,000 die of this disease. While the five-year survival has risen over the past 20 years, some groups of patients are being left behind. Today, African Americans are 2.6 times more likely to die of the disease compared to other racial groups. In this episode, Dr. Edith Mitchell of the Sidney Kimmel Can...

Jacqueline Casillas, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA Recorded on January 8, 2020 As overall survival rates for childhood cancers continue to rise, survivors face challenges related to the long-term and late effects of their diagnosis and treatment. In this episode, Jacqueline Casillas, MD, Director of the Pediatric, Adolescent and Young Adult Survivorship Program at UCLA, describes long-term and late effects experienced in the pediatric population, including the me...

Marybeth Medicke, MSN, RN, El Paso Community College, El Paso, TX Recorded on November 21, 2019 What is compassion fatigue? How does it differ from burnout? What behaviors do healthcare professionals with compassion fatigue exhibit? What can you do to stay engaged in your work? In this episode, Marybeth Medicke, MSN, RN, a registered nurse and faculty member at the El Paso Community College discusses the challenges of caring for a patient with cancer and shares her journey of leaving, and even...

Anita Kumar, MD, Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ Recorded on November 11, 2019 What is mantle cell lymphoma (MCL)? How is it diagnosed? How does it differ from chronic lymphocytic leukemia? In this episode, Dr. Anita Kumar of Memorial Sloan Kettering Cancer Center breaks down the biology of the disease, addresses new and emerging treatment options, and discusses approaches to both indolent and aggressive MCL. Tune in for a comprehensive understanding of MCL today! An...

Susan McCall, MSN, ANP-BC, AOCNP®, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on September 18, 2019 How do healthcare professionals communicate with patients about the issues related to living with a chronic disease? In this episode, Susan McCall, ANP-BC, AOCNP®, a nurse practitioner at Memorial Sloan Kettering Cancer Center in New York, discusses her role in educating patients and their caregivers on living with non-Hodgkin lymphoma, treatment, including clinical trials, fi...

Elizabeth A. Weber, BSN, RN, Heather DiFilippo, MSN, CRNP and Erin Medoff, RN, MSN, APRN Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019 In this episode, we are joined by three nurses to discuss their important and varied roles in treating patients with CAR T-cell therapy: Elizabeth Weber, who serves as a logistical nurse navigator, and Heather DiFilippo and Erin Medoff, both advanced practice nurses. Our guests discuss the importance of the c...

Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL Recorded on September 3, 2019 Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for preparative regimens, suicide genes, dual antigen binding, and so much more. Listen in today! Freder...

Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019 Tune in as Dr. Sergio Giralt and Dr. Gunjan Shah, hematologist-oncologists at Memorial Sloan Kettering Cancer Center in New York, discuss adverse effects and financial toxicities associated with chimeric antigen receptor (CAR) T-cell therapy. In this episode, Dr. Giralt discusses ...

Dennis Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019 What is CAR T-cell therapy? Listen in as Dr. Dennis Cooper, Professor of Medicine and Chief of the Bone Marrow Transplant Service at Rutgers Cancer Institute of New Jersey, reviews the principles of CAR T-cell therapy, discusses the treatment process and efficacy, and highlights future advances. Dennis Cooper, MD Chief...

Susan O’Brien, MD, University of California, Irvine, CA Recorded on April 5, 2019 In this episode, Dr. Ken Miller speaks with Dr. Susan O’Brien, a hematologist/oncologist at the University of California, Irvine about the standard of care for patients with chronic lymphocytic leukemia. Dr. O’Brien describes the biology of CLL, the complexities of available treatment options, how to choose a drug sequence, the clinical and laboratory workup, the issues surrounding watch and wait, and long-term a...

Amy Burd, PhD, Vice President of Research and Strategy, and Alissa Gentile, MSN, RN, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society Recorded on May 10, 2019 Join Dr. Ken Miller as he speaks with Dr. Amy Burd, Vice President of Research and Strategy, and Alissa Gentile, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society about LLS’ role in advancing treatment therapies for acute myeloid leukemia (AML). Their discussion focuses on th...

Brad Zebrack, PhD, MSW, The University of Michigan School of Social Work, Ann Arbor, MI Recorded on March 5, 2019 Dr. Brad Zebrack, Professor of Social Work at The University of Michigan School of Social Work in Ann Arbor, MI, shares his insights into the unique challenges faced by young adult cancer survivors. Dr. Zebrack discusses young adult survivors’ struggle for independence, challenges with body image and intimacy, issues navigating financial and career challenges, young adult survivors...

Richard, MDS survivor since 2016, Nancy, Caregiver, and Vu Duong, MD, University of Maryland School of Medicine, Baltimore, MD Recorded on February 26, 2019 In this episode, Dr. Miller speaks with Richard, an MDS survivor, his wife Nancy and treating physician, Dr. Vu Duong, an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore, MD as they discuss their unique perspectives on the patient’s treatment for MDS and the outcomes. Richard, MDS survior sinc...

Raymond Comenzo, MD, Tufts Medical Center, Boston, MA Recorded on December 14, 2018 In this episode, Dr. Raymond Comenzo, a hematologist/oncologist at Tufts University School of Medicine in Boston, MA, breaks down the biology of AL amyloidosis, how it affects organs throughout the body, and how it is being treated in the hospital today. AL amyloidosis is a rare disorder in which there is a buildup of an abnormal protein called amyloid. Amyloid is typically produced in the bone marrow, but can ...